Skip to main content

nl
fr
en
de

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human use
Veterinary use
Information for the public
Information for professionals

Home
Human use
Particular products

Particular products

Specially reglemented substances

Last updated on 11/01/2009

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

23/11/2020

Give your opinion on a genetically modified drug for the treatment of haemophilia A

19/11/2020

The federal government and the federated entities work together to vaccinate at least 8 million Belgians.

10/11/2020

Give your opinion on a genetically modified drug for the treatment of certain lung and skin cancers

30/10/2020

Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages

All news

© 2016 - FAMHP

Site map
Disclaimer